Back to results
US 11,958,807 B2Granted
Deuterated tryptamine derivatives and methods of use
AssigneeCybin IRL Limited
InventorAlex Nivorozhkin
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with a serotonin 5-HT2 receptor.
Claims9
A pharmaceutical composition, comprising:
- a polymer, and
- a compound of Formula (III-d), or a pharmaceutically acceptable salt thereof
- wherein:
- R2 is hydrogen;
- R6 and R7 are hydrogen;
- and
- R8 and R9 are —CD3.
4 more elements
Dependencies are inferred from the claim text.